Venentoclax
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 Trial (NCT07396480) | First Affiliated Hospital of Zhejiang University | 2026-03-01 |
| Venetoclax Combined With Azacitidine for Consolidation Therapy in AML (NCT07425782) | The First Affiliated Hospital of Soochow University | 2026-02-01 |
| The Maintenance Treatment of "ITIVA" in AML Patients (NCT06256627) | Henan Cancer Hospital | 2023-07-11 |
Track Venentoclax automatically
Every clearance here is in the API, with alerts when new ones post.